Review, Early Access, 2024

The clinical role of remimazolam: Protocol for a scoping review

ACTA ANAESTHESIOLOGICA SCANDINAVICA, ISSN 0001-5172, 10.1111/aas.14421

Contributors

Intzilaki, Christina V. (Corresponding author) [1] [2] [3] Davodi, Jasmin [2] [3] Vilmann, Peter [2] Moller, Ann M. [2] [3]

Affiliations

  1. [1] Herlev & Gentofte Hosp, Dept Anaesthesiol, ACES Herlev, Borgmester Ib Juuls Vej 15A, DK-2730 Herlev, Denmark
    2. [NORA names: Capital Region of Denmark; Hospital; Denmark; Europe, EU; Nordic; OECD];
  2. [2] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Div Endoscopy, Gastro Unit, Herlev, Denmark
    3. [NORA names: KU University of Copenhagen; University; Denmark; Europe, EU; Nordic; OECD];
  3. [3] Copenhagen Univ Hosp, Herlev Hosp, Dept Anaesthesiol, Herlev Anaesthesia Crit & Emergency Care Sci Unit, Herlev, Denmark
    4. [NORA names: Capital Region of Denmark; Hospital; Denmark; Europe, EU; Nordic; OECD]

Abstract

Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.

Keywords

adverse effects, benzodiazepine, economic cost, general anaesthesia, patient and operator experience, procedural sedation, remimazolam

Data Provider: Clarivate

LINKS
-

Matching Records in NORA

SUBJECTS
+

METRICS
+